Liver fibrosis plays a central role in the progression of chronic liver diseases. Despite this, no medications are currently approved specifically for the treatment of Liver fibrosis (1 ...

Liver fibrosis is the buildup of scar tissue in the liver, the organ that helps you digest food, store energy, and remove toxins. Liver fibrosis occurs as the organ tries to repair itself from ...

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. World revenue for the Liver Fibrosis ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone ...

Fibrosis prediction is an essential part of the assessment and management of patients with chronic liver disease. Blood-based biomarkers offer a number of advantages over the traditional standard ...

Liver fibrosis is a consequence of the sustained inflammatory processes underpinning chronic liver disease. Here authors show that autophagy in CD4 T cells is an important process in preventing ...

Mar. 12, 2025 — Until now, doctors knew hepatic stellate cells mainly as drivers of liver fibrosis. The actual functions of this cell type have hardly been studied to date. Researchers have now ...

Pegbelfermin shows significant improvements in liver fibrosis markers, adiponectin, and PRO-C3 concentrations in MASH patients compared to placebo. Liver stiffness and NASH CRN Fibrosis Score did ...

BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results ...

Furthermore, TUNEL-positive apoptotic cells were significantly elevated in the CCl4 group, suggesting that liver fibrosis development involves ongoing cells apoptosis and proliferation (Figure 1E).